Cheng Y, Liu J, Li Y, et al. Ebloa viral disease: Update research of etiology, pathogenic mechanism, treatment and vaccine[J]. Chinese Science Bulletin, (under review).
[2]
Jahrling P B, Geisbert T W, Johnson E D, et al. Preliminary report: Isolation of Ebola virus from monkeys imported to USA[J]. The Lancet, 1990, 335: 502-505.
[3]
Hayes C G, Burans J P, Ksiazek T G. Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus[J]. The American Journal Tropical Medicine and Hygiene, 1992, 46: 664-671.
[4]
World Health Organization. Viral haemorrhagic fever in imported monkeys[R]. Weekly Epidemiological Record, Ceneva: WHO, 1992, 67 (24): 183.
[5]
Rollin P E, Williams J, Bressler D, et al. Isolated cases of Ebola (subtype Reston) virus among quarantined non-hman primates recently imported from the Philippines to the United States[J]. Journal of Infectious Diseases, 1999, 179 (Suppl 1): 108-114.
[6]
Miranda M E, Ksiazek T G, Retuya T J, et al. Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996[J]. Journal of Infectious Diseases, 1999, 179 (Suppl 1): 115-119.
[7]
Miranda M E, White M E, Dayrit M M, et al. Seroepidemiological study of filovirus related to Ebola in the Philippines [J]. The Lancet, 1991, 337: 425-426.
[8]
Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea- Preliminary Report[J]. N Engl J Med, [2014- 08-14] http://www.nejm.org/doi/full/10.1056/NEJMoa1404505.
[9]
European Centre for Disease Prevention and Control. Outbreak of Ebola virus disease in West Africa [R/OL]. (2014-08-01)[2014-08-14]. http:// www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm. aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1141.
[10]
Bausch D G, Borchert M, Grein T, et al. Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo[J]. Emerg Infect Dis, 2003, 9: 1531-1537.
[11]
Leroy E M, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus[J]. Nature，2005, 438 (7068): 575-576.
[12]
Swanepoel R, Leman P A, Burt F J, et al. Experimental inoculation of plants and animals with Ebola virus[J]. Emerg Infect Dis, 1996, 2(4): 321-325.
[13]
Morvan J M, Deubel V, Gounon P, et al. Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic [J]. Microbes and Infection, 1999, 1: 1193-1201.
[14]
Leroy E M, Rouquet P, Formenty P, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife [J]. Science, 2004, 303(5656): 387-390.
[15]
Bermejo M, Rodríguez-Teijeiro J D, Illera G, et al. Ebola outbreak killed 5000 gorillas[J]. Science, 2006, 314 (5805): 1564.
[16]
Heinz F, Thomas W G. Ebola haemorrhagic fever [J]. The Lancet, 2011, 377: 849-862.
[17]
Groseth A, Feldmann H, Strong J E. The ecology of Ebola virus [J]. Trends in Microbiology, 2007, 15(9): 408-416.
[18]
Pan Y, Zhang W, Cui L, et al. Reston virus in domestic pigs in China [J]. Arch Virol, 2014, 159(5): 1129-1132.
[19]
Georges A J, Leroy E M, Renaud A A, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994—1997: Epidemiologic and health control issues[J]. J Infect Dis, 1999, 179(Suppl 1): 65-75.
[20]
Kuniholm M H. Bat exposure is a risk factor for Ebola virus infection[C]// Filoviruses: Recent advance and future challenges: An ICID Global Symposium, Winnipeg, Manitoba, Canada, 2006.
[21]
Peters C J, LeDuc L W. Ebola: The virus and the disease [J]. J Infect Dis, 1999, 179 (Suppl 1): 1-288.
[22]
Khan A S, Tshioko F K, Heymann D L, et al. The reemergence of Ebola haemorrhagic fever, Democratic Republic of the Congo, 1995 [J]. J Infect Dis, 1999, 179 (Suppl 1): 76-86.
[23]
Ksiazek T G, West C P, Rollin P E, et al. ELISA for the detection of antibodies to Ebola virus [J]. J Infect Dis, 1999, 179 (Suppl 1): 192-198.
[24]
Zaki S R, Shieh W J, Greer P W, et al. A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola haemorrhagic fever [J]. J Infect Dis, 1999, 179(Suppl 1): 36-47.
[25]
Jahrling P B, Geisbert T W, Jaax N K, et al. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989— 1990 U.S. epizootic [J]. Arch Virol, 1996, 11 (Suppl 1): 115-134.
[26]
Bertherat E, Renaut A, Nabias R, et al. Leptospirosis and ebola virus infection in five gold-panning villages in northeastern Gabon[J]. Am J Trop Med Hyg, 1999, 60(4): 610-615.
[27]
Rowe A K, Bertolli J, Khan A S, et al. Clinical, virologic, and immunologic follow- up of convalescent Ebola haemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo [J]. J Infect Dis, 1999, 179 (Suppl 1): 28-35.
Okware S I, Omaswa F G, Zaramba S, et al. An outbreak of Ebola in Uganda[J]. Tropical Medicine and International Health. 2002, 7(12): 1068-1075.
[30]
Kortepeter M G, Bausch D G, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever [J]. J Infect Dis, 2011, 204 (Suppl 3): 810-816.
[31]
US Food and Drug Administration. Emergency use authorizations-2014 Ebola virus emergency use authorization [EB/OL]. [2014-08-17]. http:// www.fda.gov/medicaldevices/safety/emergencysituations/ucm161496. htm.
[32]
Centres for Disease Control and Prevention. Ebola hemorrhagic feverdiagnosis[ EB/OL].[2014-08-15].http://www.cdc.gov/vhf/ebola/diagnosis/ index.html.
[33]
Fauci A S. Ebola—Underscoring the global disparities in health care resources[EB/OL]. [2014-08-17]. http://www.nejm.org/doi/full/10.1056/ NEJMp1409494.
[34]
Centre for Infectious Disease Research and Ppolicy. Experimental Ebola drug may have helped 2 US patients [EB/OL]. [2014-08-11]. http://www.cidrap.umn.edu/news-perspective/2014/08/experimental-ebola- drug-may-have-helped-2-us-patients.
[35]
Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola haemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee [J]. J Infect Dis, 1999, 179 (Suppl 1): 18-23.
[36]
Feldmann H, Jones S M, Schnittler H J, et al. Therapy and prophylaxis of Ebola virus infections [J]. Curr Opin Investig Drugs, 2005, 6(8): 823-830
[37]
Bray M, Paragas J. Experimental therapy of filovirus infections [J]. Antiviral Res, 2002, 54 (1): 1-17.
[38]
Centres for Disease Prevention and Control. Ebola hemorrhagic fever-treatment [EB/OL]. [2014-08-16]. http://www.cdc.gov/vhf/ebola/ treatment/index.html.
[39]
Huggins J W. Prospects for treatment of viral haemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug [J]. Rev Infect Dis, 1989, 11 (Suppl 4): 750-761.
[40]
Ignatyev G, Steinkasserer A, Streltsova M, et al. Experimental study on the possibility of treatment of some haemorrhagic fevers [J]. J Biotechnol, 2000, 83(1/2): 67-76.
[41]
World Health Organization. Ebola and Marburg virus disease epidemics: preparedness, alert, control, and evaluation (Interim version 1.1) [M/OL].[2014-08-10]. http://www.who.int/csr/disease/ebola/manual_EVD/en.
[42]
WorldHealthOrganization.WHOstatementonthemeetingoftheInternational Health Regulations Emergency Committee regarding the 2014 Ebola outbreak in West Africa [EB/OL]. (2014-08-08) [2014-08-10]. http:// www.who.int/mediacentre/news/statements/2014/polio-20140505/en.
[43]
Centres for Disease Prevention and Control. Ebola hemorrhagic fever- 2014 Ebola outbreak in West Africa [EB/OL]. [2014-08-24]. http://www. cdc.gov/vhf/ebola/outbreaks/guinea/index.html.
[44]
World Health Organization. Ebola haemorrhagic fever in Sudan, 1976 [J]. Bull World Health Organ, 1978, 56: 247-270.
[45]
World Health Organization. Ebola haemorrhagic fever in Zaire, 1976 [J]. Bull World Health Organ, 1978, 56: 271-293.
[46]
Cox N J, McCormick J B, Johnson K M, et al. Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA [J]. J Infect Dis, 1983, 147: 272-275.
[47]
Le Guenno B, Formenty P, Wyers M, et al. Isolation and partial characterisation of a new strain of Ebola virus [J]. The Lancet, 1995, 345: 1271-1274.
[48]
Wamala J F, Lukwago L, Malimbo M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007—2008 [J]. Emerg Infect Dis, 2010, 16(7): 1087-1092.
[49]
Emond R T, Evans B, Bowen E T, et al. A case of Ebola virus infection[J]. British Medical Journal. 1977, 2(6086): 541-544.
[50]
Borisevich I V, Markin V A, Firsova I V, et al. Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: Epidemiology, clinical pictures, and treatment [J]. Voprosy Virusologii-Problems of Virology, 2006, 51(5): 8- 16.
[51]
Akinfeyeva L A, Aksyonova O I, Vasilyevich I V, et al. A case of Ebola hemorrhagic fever[J]. Infektsionnye Bolezni, 2005, 3(1): 85-88.
[52]
Barrette R W, Metwally S A, Rowland J M, et al. Discovery of swine as a host for the Reston ebolavirus [J]. Science, 2009, 325: 204-206.
[53]
Jahrling P B, Geisbert T W, Johnson E D, et al. Preliminary report: Isolation of Ebola virus from monkeys imported to USA[J]. The Lancet, 1990, 335: 502-505.
[54]
Centers for Disease Control and Prevention. Update: Filovirus infection in animal handlers [J]. Morbidity Mortality Weekly Report, 1990, 39 (13): 221.
[55]
World Health Organization. Ebola virus disease in Guinea—23 March 2014 [EB/OL]. [2014- 03- 25]. http://www.who.int/csr/don/2014_03_ 23_ebola/en.
[56]
Pourrut X, Délicat A, Rollin P E, et al. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species [J]. J Infect Dis, 2007, 196 Suppl 2): 176-183.
[57]
Towner J S, Amman B R, Sealy T K, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats [J]. PLoS Pathogens, 2009, 5.[2014-08-14] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713404.
[58]
Leroy E M, Epelboin A, Mondonge V, et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007[J]. Vector-Borne and Zoonotic Diseases, 2009, 9: 723-728.
[59]
Bausch D G, Nichol S T, Muyembe- Tamfum J J, et al. Marburg haemorrhagic fever associated with multiple genetic lineages of virus [J]. N Engl J Med, 2006, 355: 909-919.
[60]
Formenty P, Boesch C, Wyers M, et al. Ebola virus outbreak among wild chimpanzees living in a rain forest of Cote d'Ivoire [J]. J Infect Dis, 1999, 179(Suppl 1): 120-126.
[61]
Nkoghe D, Formenty P, Leroy E M, et al. Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002[J]. Bull Soc Pathol Exot. 2005, 98 (3): 224-229.
[62]
Formenty P, Libama F, Epelboin A, et al. Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy[J]. Med Trop (Mars). 2003, 63(3): 291-295.
[63]
Feldmann H, Jones S, Klenk H D, et al. Ebola virus: From discovery to vaccine [J]. Nature Reviews Immunology, 2003, 3(8): 677-685.
[64]
Geisbert T W, Hensley L E, Larsen T, et al. Pathogenesis of Ebola haemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection [J]. Am J Pathol, 2003, 163(6): 2347-2370.
[65]
Rodriguez L L, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995 [J]. J Infect Dis, 1999, 179 (Suppl 1): 170- 176.
[66]
Piercy T J, Smither S J, Steward J A, et al. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol [J]. J Appl Microbiol. 2010, 109 (5): 1531-1539.
[67]
Geisbert T W, Daddario-Dicaprio K M, Geisbert J B, et al. Vesicular stomatitis virus- based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses [J]. Vaccine, 2008, 26 (52): 6894-6900.
[68]
Centres for Disease Control and Prevention. Interim guidance for monitoring and movement of persons with Ebola virus disease exposure[R/OL]. [2014- 08- 15]. http://www.cdc.gov/vhf/ebola/hcp/monitoringand- movement-of-persons-with-exposure.html.
[69]
Centres for Disease Control and Prevention. Ebola hemorrhagic feversigns and symptoms [EB/OL]. [2014- 08- 15]. http://www.cdc.gov/vhf/ ebola/symptoms/index.html.
[70]
Bwaka M A, Bonnet M J, Calain P. Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo: Clinical observations in 103 patients [J]. J Infect Dis, 1999, 179(Suppl 1): 1-7.
[71]
Strong J E, Grolla A, Jahrling P B, et al. Filoviruses and arenaviruses[C]// Detrick B, Hamilton R G, Folds J D. Manual of molecular and clinical laboratory immunology. 7th ed. Herndo, Virginia: ASM Press, 2006: 774-790.
[72]
MacNeil A, Farnon E C, Morgan O W, et al. Filovirus outbreak detection and surveillance: Lessons from Bundibugyo[J]. J Infect Dis, 2011, 204 (Suppl 3): 761-767.
[73]
Borchert M, Mutyaba I, van Kerkhove M D, et al. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: Outbreak description and lessons learned [J]. BMC Infect Dis, 2011, 11: 357.
[74]
World Health Organization, Centres for Disease Control and Prevention. Infection Control for Viral Haemorrhagic Fevers [R/OL]. [2014-08-15]. http://www.cdc.gov/vhf/abroad/pdf/african-healthcare-setting-vhf.pdf.
[75]
Dowell S F, Mukunu R, Ksiazek T G, et al. Transmission of Ebola haemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995 [J]. J Infect Dis, 1999, 179 (Suppl 1): 87-91.
[76]
Lloyd E S, Zaki S R, Rollin P E, et al. Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: A model for early detection and prevention of Ebola haemorrhagic fever [J]. J Infect Dis, 1999, 179 (Suppl 1): 274-280.
